|
[1]COUSSENS LM,WERB Z.Inflammation and cancer[J].Nature,2002,420(6917):860-867.
|
|
[2]GRIVENNIKOV SI,GRETEN FR,KARIN M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899.
|
|
[3]JAISWAL M,LARUSSO NF,BURGART LJ,et al.Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism[J].Cancer Res,2000,60(1):184-190.
|
|
[4]DAN J,ZHANG Y,PENG Z,et al.Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation[J].PLo S One,2013,8(3):e58184.
|
|
[5]YANG X,HUANG Y,FENG JF,et al.Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer:a meta-analysis[J].Onco Targets Ther,2015,21(8):789-794.
|
|
[6]ZHANG X,ZHANG W,FENG LJ.Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer:a meta-analysis[J].PLo S One,2014,9(11):e111906.
|
|
[7]LI MX,LIU XM,ZHANG XF,et al.Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer:a systematic review and meta-analysis[J].Int J Cancer,2014,134(10):2403-2413.
|
|
[8]YANG JJ,HU ZG,SHI WX,et al.Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer:a meta-analysis[J].World J Gastroenterol,2015,21(9):2807-2815.
|
|
[9]WEI Y,JIANG YZ,QIAN WH.Prognostic role of NLR in urinary cancers:a meta-analysis[J].PLo S One,2014,9(3):e92079.
|
|
[10]PENG B,WANG YH,LIU YM,et al.Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer:a systemic review and meta-analysis[J].Int J Clin Exp Med,2015,8(3):3098-3106.
|
|
[11]XIAO WK,CHEN D,LI SQ,et al.Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma:a meta-analysis[J].BMC Cancer,2014,14(1):1-10.
|
|
[12]LIMAYE AR,CLARK V,SOLDEVILA-PICO C,et al.Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma[J].Hepatol Res,2013,43(7):757-764.
|
|
[13]MOTOMURA T,SHIRABE K,MANO Y,et al.Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment[J].J Hepatol,2013,58(1):58-64.
|
|
[14]OKAMURA Y,ASHIDA R,ITO T,et al.Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma[J].World J Surg,2015,39(6):1501-1509.
|
|
[15]DAN J,ZHANG Y,PENG Z,et al.Postoperative neutrophil-tolymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation[J].PLo S One,2013,8(3):e58184.
|
|
[16]Mc NALLY ME,MARTINEZ A,KHABIRI H,et al.Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization[J].Ann Surg Oncol,2013,20(3):923-928.
|
|
[17] PINATO DJ,SHARMA R.An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma[J].Transl Res,2012,160(2):146-152.
|
|
[18]GAO F,LI X,GENG M,et al.Pretreatment neutrophil-lymphocyte ratio:an independent predictor of survival in patients with hepatocellular carcinoma[J].Medicine(Baltimore),2015,94(11):e639.
|
|
[19]SUN XD,SHI XJ,CHEN YG,et al.Elevated preoperative neutrophil-lymphocyte ratio is associated with poor prognosis in hepatocellular carcinoma patients treated with liver transplantation:a meta-analysis[J].Gastroenterol Res Pract,2016,2016:4743808.
|
|
[20]LIAO W,ZHANG J,ZHU Q,et al.Preoperative neutrophil-tolymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection[J].Transl Oncol,2014,7(2):248-255.
|
|
[21]FU SJ,SHEN SL,LI SQ,et al.Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBVassociated hepatocellular carcinoma after radical hepatectomy[J].Med Oncol,2013,30(4):721.
|
|
[22]MANO Y,SHIRABE K,YAMASHITA Y,et al.Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma:a retrospective analysis[J].Ann Surg,2013,258(2):301-305.
|
|
[23]CHEN TM,LIN CC,HUANG PT,et al.Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation[J].J Gastroenterol Hepatol,2012,27(3):553-561.
|
|
[24]TAIJIRI K,BABA H,KAWAI K,et al.Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection[J].J Gastroenterol Hepatol,2016.[Epub ahead of print]
|
|
[25]PINATO DJ,SHARAMA R.An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma[J].Transl Res,2012,160(2):146-152.
|
|
[26] CHEN TM,LIN CC,HUANG PT,et al.Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation[J].J Gastroenterol Hepatol,2012,27(3):553-561.
|
|
[27]POLLARD JW.Tumour-educated macrophages promote tumour progression and metastasis[J].Nat Rev Cancer,2004,4(1):71-78.
|
|
[28]KONO H,FUJII H,OGIKU M,et al.Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice[J].J Immunol,2011,187(9):4818-4825.
|
|
[29]POON RT,FAN ST,LO CM,et al.Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function:implications for a strategy of salvage transplantation[J].Ann Surg,2002,235(3):373-382.
|
|
[30]POON RT,FAN ST,LO CM,et al.Improving survival results after resection of hepatocellular carcinoma:a prospective study of 377 patients over 10 years[J].Ann Surg,2001,234(1):63-70.
|
|
[31]KUSUMANTO YH,DAM WA,HOSPERS GA,et al.Platelets and granulocytes,in particular the neutrophils,form important compartments for circulating vascular endothelial growth factor[J].Angiogenesis,2003,6(4):283-287.
|
|
[32]WU Y,ZHAO Q,PENG C,et al.Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop[J].J Pathol,2011,225(3):438-447.
|
|
[33]Mc DONALD B,SPICER J,GIANNAIS B,et al.Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms[J].Int J Cancer,2009,125(6):1298-1305.
|
|
[34]SCHREIBER RD,OLD LJ,SMYTH MJ.Cancer immunoediting:integrating immunity's roles in cancer suppression and promotion[J].Science,2011,331(6024):1565-1570.
|
|
[35]MULLER I,MUNDER M,KROPF P,et al.Polymorphonuclear neutrophils and T lymphocytes:strange bedfellows or brothers in arms?[J].Trends Immunol,2009,30(11):522-530.
|
|
[36]GU LL,LIU HM,ZHOU XB,et al.Efficacy of integrated traditional Chinese and Western medicine therapy based on vital qistrengthening,detoxicating,and qi stagnation-removing prescriptions in treatment of primary liver cancer[J].J Tradit Chin Med,2014,55(7):576-579.(in Chinese)谷莉莉,刘慧敏,周小兵,等.基于扶正解毒消积方的中西医结合方案治疗原发性肝癌的疗效分析[J].中医杂志,2014,55(7):576-579.
|
|
[37]LIU Y.Effect of vital qi-strengthening,detoxicating,and qi stagnation-removing prescriptions on 2-year survival rate and related mechanisms of action in patients with primary liver cancer[D].Beijing:Beijing Univ Chin Med,2015.(in Chinese)刘尧.扶正解毒消积方对原发性肝癌2年生存率的影响和作用机制研究[D].北京:北京中医药大学,2015.
|
DownLoad: